India Respiratory Care Devices Market Overview, 2031

The respiratory devices sector in India has significantly transformed, driven by the high incidence of chronic respiratory illnesses like COPD and asthma, in to increasing levels of air pollution and tobacco consumption. India bears an outsized part of the burden related to COPD and asthma, with millions impacted and considerable levels of illness and death linked to chronic respiratory conditions highlighting the pressing demand for effective respiratory care options. Research indicates that millions of people in India suffer from COPD and similar ailments, and respiratory illnesses rank among the top causes of mortality and disability in the nation. Recent seasonal increases in cases due to pollution demonstrate how environmental influences amplify the need for clinical and supportive respiratory devices in both city and rural settings. This significant disease burden has sparked affordable innovation throughout India's medical technology landscape. Homegrown ventilators like the AgVa Ventilator and extremely affordable models such as the Super Ventilator showcase India's initiative toward budget-friendly, locally crafted solutions designed for resource-constrained environments, filling the void left by costly imports. Furthermore, patents for low-cost respiratory support devices and equipment for protecting neonatal lungs emphasize ongoing grassroots developments that focus on accessibility and affordability in high-demand areas. Technical versatility is also gaining importance, with portable oxygen concentrators, small nebulizers, and smartphone-compatible control features helping to link hospital and home care, especially for the long-term management of COPD and asthma. These advancements are in line with changing care models in India, where home-based treatments and remote monitoring are increasingly adopted for managing chronic illnesses outside conventional medical facilities.

According to the research report, " India Respiratory Devices Market Overview, 2031," published by Bonafide Research, the India Respiratory Devices market is anticipated to grow at more than 9.94% CAGR from 2026 to 2031. India's respiratory devices sector is on a promising growth path, fueled by the high rates of respiratory ailments like COPD and asthma, coupled with enhanced healthcare funding and technology adoption. Portable and wearable devices, non-invasive treatments, and the growing number of COPD and asthma sufferers are pivotal drivers of this growth. Recent advancements indicate a shift from conventional hospital equipment to more accessible technology. For instance, the portable oxygen concentrator market is expanding as home care becomes increasingly common, highlighting the consumer need for practical and inexpensive devices in both urban and rural areas of India. Local manufacturers and innovation hubs like the Andhra Pradesh MedTech Zone AMTZ are enhancing India’s manufacturing capabilities, decreasing reliance on imports and facilitating the domestic production of ventilators, oxygen concentrators, and other respiratory devices during and post-COVID-19 stimulus, thereby improving critical care infrastructure. In spite of this growth, a large portion of advanced respiratory equipment still comes from imports, creating chances for Indian companies to produce cost-effective alternatives that are sensitive to local pricing. The rising health challenges in rural areas, alongside the increase in pollution-related respiratory conditions, drives the need for budget-friendly devices, encouraging market growth in tier-2 and tier-3 cities and local markets where access to sophisticated respiratory care has been limited.

In India, the market for respiratory devices is divided based on product categories into therapeutic devices, monitoring devices, diagnostic devices, and consumables & accessories. Each category reveals distinct demand trends influenced by the prevalence of diseases, accessibility to healthcare, and treatment pathways. Among these, diagnostic & monitoring devices, which include spirometers, pulse oximeters, peak flow meters, sleep testing equipment, and capnographs, dominate the market share. This leadership is due to the growing emphasis on early diagnosis and continuous monitoring of respiratory ailments such as asthma, COPD, and sleep apnea, in to efforts by government and private sectors to provide primary and secondary healthcare facilities with necessary diagnostic tools for prompt treatment. An ongoing focus on lung function assessments and oxygen saturation monitoring is significantly directing purchasing decisions across health facilities throughout the country. Therapeutic devices, which consist of ventilators, oxygen concentrators, CPAP/BiPAP machines, nebulizers, humidifiers, and inhalers, are crucial in treating and managing both chronic and acute respiratory conditions. The significant prevalence of COPD and asthma in India, worsened by pollution and seasonal factors, has increased the necessity for these therapeutic tools. Devices for oxygen therapy and portable nebulizers are frequently utilized in hospital ICUs and home care settings. Market evaluations showcase the strong growth potential of the therapeutic segment, with oxygen concentrators particularly leading in revenue generation and anticipated to continue as major revenue contributors into the 2030s. Monitoring devices are still attracting funding as healthcare providers and tech developers incorporate digital functionalities like remote data sharing and immediate notifications to enhance the management of chronic diseases. These devices assist in optimizing clinical judgments, particularly during COPD flare-ups and post-COVID respiratory assistance.

India Respiratory Devices market by end user is divided into hospitals, ambulatory care centers, home care settings and other user. The segmentation of end users in India’s respiratory device market encompassing hospitals, ambulatory care centers ACCs, home care environments, and users illustrates the country's multi-tiered healthcare system and the changing landscape of respiratory care provision. Hospitals and clinics represent the largest segment of end users, driven by their pivotal role in diagnosing and treating both urgent and long-standing respiratory conditions. Leading medical facilities, especially in major and tier-1 cities, are outfitted with comprehensive respiratory care departments, intensive care units ICUs, and pulmonary units requiring a broad range of equipment ventilators for severe respiratory issues, oxygen therapy setups for low oxygen levels, diagnostic devices for lung function measurement, and monitoring gadgets for critical care. Hospitals also utilize digital healthcare systems like integrated monitoring setups that improve patient tracking and health results. Ambulatory Care Centers ACCs which include respiratory clinics, outpatient pulmonary rehabilitation facilities, and sleep laboratories are increasingly acknowledged as important mid-level care centers focused on early detection and ongoing management of diseases. These centers implement diagnostic spirometry, systems for sleep studies, and portable monitoring equipment to assist in the care of COPD, asthma, and sleep apnea beyond hospital walls. The ACC segment benefits from growing understanding among healthcare professionals and patients, particularly concerning chronic condition tracking and therapy modifications without needing full hospitalization. The home care settings segment is one of the rapidly expanding areas in India’s respiratory device market. As individuals with long-term conditions look for accessible and affordable care, home respiratory support such as portable oxygen generators, CPAP/BiPAP devices, and smart nebulizers with remote monitoring features is increasingly adopted. This trend is bolstered by rising disposable incomes, the growth of telehealth resources, and greater comfort with technology-assisted health solutions. Home care enables patients with chronic COPD or sleep apnea to effectively manage their conditions while reducing hospital visits, highlighting a broader shift toward decentralized healthcare in India.

"Considered in this report
• Historic Year: 2020
• Base year: 2025
• Estimated year: 2026
• Forecast year: 2031



Aspects covered in this report
• Respiratory Care Devices Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product Type
• Therapeutic Devices (Inhalers,Ventilators,Positive Airway Pressure (PAP) Devices,Humidifiers,Nebulizers,Others(Oxygen Concentrators, oxygen Hood))
• Monitoring Devices (Pulse Oximeters,Gas Analyzers,Others)
• Diagnostic Devices (Spirometers,Polysomnography Devices,Peak Flow Meters,Others)
• Consumables and Accessories (Disposable Resuscitators,Breathing Circuits,Masks,Tracheostomy Tubes,Others(Nasal Cannulas))
By Disease Indication
• Chronic Obstructive Pulmonary disease (COPD)
• Sleep Apnea
• Asthma
• Infectious Diseases
• Other disease Indications (Respiratory Distress Syndrome, cystic Fibrosis)

By End User
• Hospitals
• Ambulatory Care Centers (ACCs)
• Home care Settings
• Other End User
"